Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 193

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Open access
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., Diekema, D. J. · 2006 · Journal of Clinical Microbiology

Abstract

Caspofungin is being used increasingly as therapy for invasive candidiasis. Prospective sentinel surveillance for emergence of in vitro resistance to caspofungin among invasive Candida spp. isolates is indicated. We determined the in vitro activity of caspofungin against 8,197 invasive (bloodstream or sterile-site) unique patient isolates of Candida collected from 91 medical centers worldwide from 1 January 2001 to 31 December 2004. We performed antifungal susceptibility testing according to the Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS) M27-A2 method and used a 24-h prominent inhibition endpoint for determination of the MIC. Of 8,197 invasive Candida spp. isolates, species distribution was as follows: 54% Candida albicans , 14% C. glabrata , 14% C. parapsilosis , 11% C. tropicalis , 3% C. krusei , and 4% other Candida spp. Overall, caspofungin was very active against Candida (MIC 50 /MIC 90 , 0.03/0.25 μg/ml; 98.2% were inhibited at a MIC of ≤0.5 μg/ml and 99.7% were inhibited at a MIC of ≤1 μg/ml). Results by species (expressed as MIC 50 /MIC 90 and the percentage inhibited at ≤1 μg/ml) were as follows: C. albicans , 0.03/0.06, 99.9; C. glabrata , 0.03/0.06, 99.9; C. parapsilosis , 0.5/0.5, 99.0; C. tropicalis , 0.03/0.06, 99.7; C. krusei , 0.12/0.5, 99.0; and C. guilliermondii , 0.5/1, 94.4. Of the 25 isolates with caspofungin MICs of >1 μg/ml, 12 isolates were C. parapsilosis , 6 isolates were C. guilliermondii , 2 isolates were C. rugosa , and 1 isolate each was C. albicans , C. glabrata , C. krusei , C. lusitaniae , and C. tropicalis . There was no significant change in caspofungin activity over the 4-year study period. Likewise, there was no difference in activity by geographic region. Caspofungin has excellent in vitro activity against invasive clinical isolates of Candida from centers worldwide. Our prospective sentinel surveillance reveals no evidence of emerging caspofungin resistance among invasive clinical isolates of Candida .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.44.3.760-763.2006

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 193

Metadata

Authors
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J.
Venue
Journal of Clinical Microbiology
Published
2006-03
Volume
44
Issue
3
Pages
760-763
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2162007379
Cited by
193
References
4
FWCI
16.44
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance. https://app.cochat.ai/papers/10.1128/jcm.44.3.760-763.2006
The paper
Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2006). In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.44.3.760-763.2006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.